Numerous methods have emerged, or have been re-deployed, to study the SARS-CoV-2 virus and to introduce novel drugs and vaccines.
Scientists at Integral Molecular have built several tools to help researchers in the field of SARS-CoV-2 research, drug and vaccine discovery. Many of these methods rely on the iQue® advanced high throughput flow cytometry platform as a final readout.
This webinar describes how flow cytometry methods facilitate Integral Molecular developments.
Key webinar highlights:
- The use of reporter viruses in drug and vaccine discovery
- Specificity mapping of lead mAb therapeutic candidates
- The significance of epitope mapping, for mitigating neutralization escape
- Live questions and answers
Speakers:
Tabb Sullivan l Integral Molecular
Rachel Fong l Integral Molecular
> Register Now